Baxter Oncology GmbH

Ukraine

All drugs from this manufacturer

  • BORTEZOMIB-BAXTER

    The drug is used for the treatment of multiple myeloma (as part of combination therapy or as monotherapy) and mantle cell lymphoma.

    Dosage form: powder for injection solution

    Active substance Dosage
    bortezomib 3.5 mg

    ATC: L01XG01